V221 Concomitant Use Study With Pneumococcal Conjugate Vaccine (V221-019)

Clinical trial NCT00109343 · COMPLETED

Trial details

NCT number: NCT00109343
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Measles Mumps Rubella Varicella

Start date: 2006-03-01
Primary completion: 2007-09-01
Enrollment: 1027

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.